Letairis® (ambrisentan) is a medicine prescribed to treat pulmonary arterial hypertension (PAH) in adults. It works by preventing the blood vessels from constricting (narrowing).
This medicine comes as a tablet that is taken once daily. Your individual dosage will be calculated based on how you respond to the drug, other medications you are taking, and various other factors. Some of the commonly reported side effects include swelling, nasal congestion, and inflamed sinuses.
Before starting treatment with Letairis, your healthcare provider will need information on your medical history and any other medications, vitamins, or supplements you are using. He or she will also ask if you have certain lung problems or any allergies, and (if you are a woman) if you are pregnant.
(For more details on this medication, click Letairis. This Web page presents information on how this drug performed in clinical trials, important safety concerns, and more.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Letairis [package insert]. Foster City, CA: Gilead Sciences, Inc.;2012 October.
Ambrisentan. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2013. Available from Wolters Kluwer Health, Inc. Accessed May 31, 2013.
Letairis Web site. Available at: http://www.Letairis.com/. Accessed June 3, 2013.
Lexi-Interact [computer program]. Lexi-Comp, Inc.; June 3, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click